Accendra Health Secures $1.5B+ Debt Restructuring, Reduces Funded Debt by $371M, Extends Maturities

summarizeSummary

Accendra Health announced a comprehensive balance sheet optimization exceeding $1.5 billion, securing new first and second lien notes, a new $300 million revolving credit facility, and reducing funded debt by $371 million, significantly extending its debt maturity profile. This critical restructuring provides essential liquidity and operational flexibility for the financially distressed company.

check_boxKey Events

• Comprehensive Debt Restructuring Initiated

  Accendra Health entered into a Commitment Letter for a balance sheet optimization transaction exceeding $1.5 billion, aiming to address its financial challenges.

• New Capital and Debt Exchange

  The transaction includes a new $326.25 million issuance of 9.000% Senior Secured First Lien Notes due 2032 and an exchange of existing notes for new First Lien Notes (at 98.50% of face value) and 9.750% Senior Secured Second Lien Notes due 2033 (at 85.50% and 86.50% of face value).

• Enhanced Liquidity and Debt Repayment

  A new $300.0 million revolving credit facility due 2030 will replace the existing one. Proceeds from the new money issuance and cash on hand will repay outstanding borrowings under the Term A facility and existing revolving credit facility.

• Significant Debt Reduction and Maturity Extension

  The transaction is expected to reduce funded debt by $371 million, significantly extending the company's weighted average debt maturity profile to approximately 5.5 years.

auto_awesomeAnalysis

This filing details a critical and comprehensive balance sheet optimization for Accendra Health, a company that recently reported a substantial net loss and negative shareholder equity. The transaction, valued at over $1.5 billion, is designed to address immediate liquidity concerns and extend the company's debt maturity profile. While existing noteholders are exchanging their debt at a discount and the new debt carries high interest rates, the successful securing of new first and second lien notes, a new revolving credit facility, and a significant reduction in overall funded debt (by $371 million) is a major de-risking event. This restructuring provides the company with a much-needed runway to stabilize its operations and pursue its home-based care strategy, shifting focus from financial distress to operational execution and growth.